BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 32023884)

  • 1. Revelation of Proteomic Indicators for Colorectal Cancer in Initial Stages of Development.
    Kopylov AT; Stepanov AA; Malsagova KA; Soni D; Kushlinsky NE; Enikeev DV; Potoldykova NV; Lisitsa AV; Kaysheva AL
    Molecules; 2020 Jan; 25(3):. PubMed ID: 32023884
    [No Abstract]   [Full Text] [Related]  

  • 2. Interplay between post-translational cyclooxygenase-2 modifications and the metabolic and proteomic profile in a colorectal cancer cohort.
    Prieto P; Jaén RI; Calle D; Gómez-Serrano M; Núñez E; Fernández-Velasco M; Martín-Sanz P; Alonso S; Vázquez J; Cerdán S; Peinado MÁ; Boscá L
    World J Gastroenterol; 2019 Jan; 25(4):433-446. PubMed ID: 30700940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative proteomics, network analysis and post-translational modification identification reveal differential profiles of plasma Con A-bound glycoprotein biomarkers in gastric cancer.
    Uen YH; Lin KY; Sun DP; Liao CC; Hsieh MS; Huang YK; Chen YW; Huang PH; Chen WJ; Tai CC; Lee KW; Chen YC; Lin CY
    J Proteomics; 2013 May; 83():197-213. PubMed ID: 23541716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A proteomic classifier panel for early screening of colorectal cancer: a case control study.
    Hua H; Wang T; Pan L; Du X; Xia T; Fa Z; Gu L; Gao F; Yu C; Gao F; Liao L; Shen Z
    J Transl Med; 2024 Feb; 22(1):188. PubMed ID: 38383428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Inter-Alpha-Trypsin Inhibitor Heavy Chains H3 and H4 Serve as Novel Diagnostic Biomarkers in Human Colorectal Cancer.
    Jiang X; Bai XY; Li B; Li Y; Xia K; Wang M; Li S; Wu H
    Dis Markers; 2019; 2019():5069614. PubMed ID: 31481982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma clusterin as a candidate pre-diagnosis marker of colorectal cancer risk in the Florence cohort of the European Prospective Investigation into Cancer and Nutrition: a pilot study.
    Bertuzzi M; Marelli C; Bagnati R; Colombi A; Fanelli R; Saieva C; Ceroti M; Bendinelli B; Caini S; Airoldi L; Palli D
    BMC Cancer; 2015 Feb; 15():56. PubMed ID: 25884309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of type I collagen during tumorigenesis of colorectal cancer revealed by quantitative proteomic analysis.
    Zou X; Feng B; Dong T; Yan G; Tan B; Shen H; Huang A; Zhang X; Zhang M; Yang P; Zheng M; Zhang Y
    J Proteomics; 2013 Dec; 94():473-85. PubMed ID: 24332065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family.
    Peltier J; Roperch JP; Audebert S; Borg JP; Camoin L
    J Proteomics; 2016 Oct; 148():139-48. PubMed ID: 27492143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteins in stool as biomarkers for non-invasive detection of colorectal adenomas with high risk of progression.
    Komor MA; Bosch LJ; Coupé VM; Rausch C; Pham TV; Piersma SR; Mongera S; Mulder CJ; Dekker E; Kuipers EJ; van de Wiel MA; Carvalho B; Fijneman RJ; Jimenez CR; Meijer GA; de Wit M
    J Pathol; 2020 Mar; 250(3):288-298. PubMed ID: 31784980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug Sensitivity.
    Wang J; Mouradov D; Wang X; Jorissen RN; Chambers MC; Zimmerman LJ; Vasaikar S; Love CG; Li S; Lowes K; Leuchowius KJ; Jousset H; Weinstock J; Yau C; Mariadason J; Shi Z; Ban Y; Chen X; Coffey RJC; Slebos RJC; Burgess AW; Liebler DC; Zhang B; Sieber OM
    Gastroenterology; 2017 Oct; 153(4):1082-1095. PubMed ID: 28625833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma-Based Proteomics Profiling of Patients with Hyperthyroidism after Antithyroid Treatment.
    Masood A; Benabdelkamel H; Ekhzaimy AA; Alfadda AA
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32575434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing the colorectal cancer proteome for biomarkers: Current status and perspectives.
    Lee PY; Chin SF; Low TY; Jamal R
    J Proteomics; 2018 Sep; 187():93-105. PubMed ID: 29953962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics of post-translational modifications in colorectal cancer: Discovery of new biomarkers.
    Zhu G; Jin L; Sun W; Wang S; Liu N
    Biochim Biophys Acta Rev Cancer; 2022 Jul; 1877(4):188735. PubMed ID: 35577141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An informatics-assisted label-free approach for personalized tissue membrane proteomics: case study on colorectal cancer.
    Han CL; Chen JS; Chan EC; Wu CP; Yu KH; Chen KT; Tsou CC; Tsai CF; Chien CW; Kuo YB; Lin PY; Yu JS; Hsueh C; Chen MC; Chan CC; Chang YS; Chen YJ
    Mol Cell Proteomics; 2011 Apr; 10(4):M110.003087. PubMed ID: 21209152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
    Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
    Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic and cytokine plasma biomarkers for predicting progression from colorectal adenoma to carcinoma in human patients.
    Choi JW; Liu H; Shin DH; Yu GI; Hwang JS; Kim ES; Yun JW
    Proteomics; 2013 Aug; 13(15):2361-74. PubMed ID: 23606366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-expression Network Analysis Identified Key Proteins in Association With Hepatic Metastatic Colorectal Cancer.
    Yang W; Shi J; Zhou Y; Liu T; Li J; Hong F; Zhang K; Liu N
    Proteomics Clin Appl; 2019 Nov; 13(6):e1900017. PubMed ID: 31397080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rat-to-human search for proteomic alterations reveals transgelin as a biomarker relevant to colorectal carcinogenesis and liver metastasis.
    Peng J; Zhang Q; Ma Y; Wang Y; Huang L; Zhang P; Chen J; Qin H
    Electrophoresis; 2009 Sep; 30(17):2976-2987. PubMed ID: 19711377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating proteomics and transcriptomics for the identification of potential targets in early colorectal cancer.
    Yang W; Shi J; Zhou Y; Liu T; Zhan F; Zhang K; Liu N
    Int J Oncol; 2019 Aug; 55(2):439-450. PubMed ID: 31268166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential role of ORM2 in the development of colorectal cancer.
    Zhang X; Xiao Z; Liu X; Du L; Wang L; Wang S; Zheng N; Zheng G; Li W; Zhang X; Dong Z; Zhuang X; Wang C
    PLoS One; 2012; 7(2):e31868. PubMed ID: 22363757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.